Aytu BioPharma, Inc. (AYTU) vs Bright Green Corporation (BGXXQ)

Aytu BioPharma, Inc. and Bright Green Corporation are both Drug Manufacturers Specialty & Generic companies. Aytu BioPharma, Inc. is the larger, with a market value of $25.1M against $13.9M — 1.8× the size. Bright Green Corporation has the higher net margin (0.00% vs −24.8%) and the lower return on invested capital (−39.4% vs −20.0%). Across the 13 metrics below, Aytu BioPharma, Inc. leads on 7 and Bright Green Corporation on 6.

Valuation

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.48 n/m 2.25
P/B 0.78 n/m 1.90
Price to free cash flow 8.53 n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.32 n/m 2.56
Earnings yield (51.16%) 0.00% (2.99%)
Free cash flow yield 11.72% 0.00% 0.00%

Profitability

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
Gross margin 63.95% 0.00% 53.94%
Operating margin (14.44%) 0.00% 0.00%
Net margin (24.76%) 0.00% 0.00%
Free cash flow margin 5.62% 0.00% 0.00%
Return on equity (52.55%) (73.60%) (0.40%)
Return on assets (12.44%) (44.80%) (3.32%)
Return on invested capital (19.99%) (39.35%) 0.00%

Growth

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (13.27%) — 10.01%
EPS growth (last fiscal year) 46.44% 58.82% —
Revenue growth, 5-year CAGR (2.59%) — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
Debt to equity 0.48 0.07 0.05
Current ratio 1.13 0.01 2.31
Net debt to EBITDA 2.17 (0.02) 0.85

Dividend

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 — 0.00

Size

Metric AYTU BGXXQ Drug Manufacturers Specialty & Generic median
Market cap 25.10m 13.88m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack